Impact of Race, Ethnicity, and Multimodality Biomarkers on the Incidence of New-Onset Heart Failure with Preserved Ejection Fraction (from the Multi-Ethnic Study of Atherosclerosis)

American Journal of Cardiology

Volumn 117, Issue 9, 2016, Pages 1474-1481

  Silverman, Michael G ^a   Patel, Birju ^b   Blankstein, Ron ^a   Lima, Joao A C ^c   Blumenthal, Roger S ^d   Nasir, Khurram ^d,e   Blaha, Michael J ^d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e MIAMI CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALCIUM; HORMONE PRECURSOR; INTERLEUKIN 6; TROPONIN T;

ADULT; AGE; AGED; ARTICLE; BLACK PERSON; BODY MASS; CAUCASIAN; CHINESE; CONTROLLED STUDY; CORONARY ARTERY CALCIUM SCORE; DIABETES MELLITUS; DISEASE EXACERBATION; ELECTROCARDIOGRAPHY; ETHNICITY; FEMALE; FOLLOW UP; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HISPANIC; HUMAN; HYPERTENSION; INCIDENCE; INFLAMMATION; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RACE; RISK FACTOR; ATHEROSCLEROSIS; BLOOD; CLINICAL TRIAL; COHORT ANALYSIS; ETHNIC GROUP; ETHNOLOGY; HEART FAILURE; HEART STROKE VOLUME; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; STATISTICS AND NUMERICAL DATA; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; BIOMARKERS; COHORT STUDIES; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; STROKE VOLUME; UNITED STATES;

EID: 84962623053     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2016.02.017     Document Type: Article

References (25)

1. C.S. Lam, E. Donal, E. Kraigher-Krainer, and R.S. Vasan Epidemiology and clinical course of heart failure with preserved ejection fraction Eur J Heart Fail 13 2011 18 28
2. A.M. Shah, and M.A. Pfeffer The many faces of heart failure with preserved ejection fraction Nat Rev Cardiol 9 2012 555 556
3. J. Butler, G.C. Fonarow, M.R. Zile, C.S. Lam, L. Roessig, E.B. Schelbert, S.J. Shah, A. Ahmed, R.O. Bonow, J.G. Cleland, R.J. Cody, O. Chioncel, S.P. Collins, P. Dunnmon, G. Filippatos, M.P. Lefkowitz, C.N. Marti, J.J. McMurray, F. Misselwitz, S. Nodari, C. O'Connor, M.A. Pfeffer, B. Pieske, B. Pitt, G. Rosano, H.N. Sabbah, M. Senni, S.D. Solomon, N. Stockbridge, J.R. Teerlink, V.V. Georgiopoulou, and M. Gheorghiade Developing therapies for heart failure with preserved ejection fraction: current state and future directions JACC Heart Fail 2 2014 97 112
4. K. Patel, G.C. Fonarow, D.W. Kitzman, I.B. Aban, T.E. Love, R.M. Allman, M. Gheorghiade, and A. Ahmed Angiotensin receptor blockers and outcomes in real-world older patients with heart failure and preserved ejection fraction: a propensity-matched inception cohort clinical effectiveness study Eur J Heart Fail 14 2012 1179 1188
5. M.M. Redfield, H.H. Chen, B.A. Borlaug, M.J. Semigran, K.L. Lee, G. Lewis, M.M. LeWinter, J.L. Rouleau, D.A. Bull, D.L. Mann, A. Deswal, L.W. Stevenson, M.M. Givertz, E.O. Ofili, C.M. O'Connor, G.M. Felker, S.R. Goldsmith, B.A. Bart, S.E. McNulty, J.C. Ibarra, G. Lin, J.K. Oh, M.R. Patel, R.J. Kim, R.P. Tracy, E.J. Velazquez, K.J. Anstrom, A.F. Hernandez, A.M. Mascette, E. Braunwald RELAX Trial Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial JAMA 309 2013 1268 1277
6. F. Edelmann, R. Wachter, A.G. Schmidt, E. Kraigher-Krainer, C. Colantonio, W. Kamke, A. Duvinage, R. Stahrenberg, K. Durstewitz, M. Löffler, H.D. Düngen, C. Tschöpe, C. Herrmann-Lingen, M. Halle, G. Hasenfuss, G. Gelbrich, B. Pieske Aldo-DHF Investigators Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial JAMA 309 2013 781 791
7. B. Pitt, M.A. Pfeffer, S.F. Assmann, R. Boineau, I.S. Anand, B. Claggett, N. Clausell, A.S. Desai, R. Diaz, J.L. Fleg, I. Gordeev, B. Harty, J.F. Heitner, C.T. Kenwood, E.F. Lewis, E. O'Meara, J.L. Probstfield, T. Shaburishvili, S.J. Shah, S.D. Solomon, N.K. Sweitzer, S. Yang, S.M. McKinlay TOPCAT Investigators Spironolactone for heart failure with preserved ejection fraction N Engl J Med 370 2014 1383 1392
8. M.M. Redfield, K.J. Anstrom, J.A. Levine, G.A. Koepp, B.A. Borlaug, H.H. Chen, M.M. LeWinter, S.M. Joseph, S.J. Shah, M.J. Semigran, G.M. Felker, R.T. Cole, G.R. Reeves, R.J. Tedford, W.H. Tang, S.E. McNulty, E.J. Velazquez, M.R. Shah, E. Braunwald NHLBI Heart Failure Clinical Research Network Isosorbide mononitrate in heart failure with preserved ejection fraction N Engl J Med 373 2015 2314 2324
9. J.E. Ho, A. Lyass, D.S. Lee, R.S. Vasan, W.B. Kannel, M.G. Larson, and D. Levy Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction Circ Heart Fail 6 2013 279 286
10. F.P. Brouwers, R.A. de Boer, P. van der Harst, A.A. Voors, R.T. Gansevoort, S.J. Bakker, H.L. Hillege, D.J. van Veldhuisen, and W.H. van Gilst Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND Eur Heart J 34 2013 1424 1431
11. D.E. Bild, D.A. Bluemke, G.L. Burke, R. Detrano, A.V. Diez Roux, A.R. Folsom, P. Greenland, D.R. Jacob Jr., R. Kronmal, K. Liu, J.C. Nelson, D. O'Leary, M.F. Saad, S. Shea, M. Szklo, and R.P. Tracy Multi-ethnic study of atherosclerosis: objectives and design Am J Epidemiol 156 2002 871 881
12. A.S. Levey, L.A. Stevens, C.H. Schmid, Y.L. Zhang, A.F. Castro III, H.I. Feldman, J.W. Kusek, P. Eggers, F. Van Lente, T. Greene, J. Coresh CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) A new equation to estimate glomerular filtration rate Ann Intern Med 150 2009 604 612
13. J.J. Carr, J.C. Nelson, N.D. Wong, M. McNitt-Gray, Y. Arad, D.R. Jacobs Jr., S. Sidney, D.E. Bild, O.D. Williams, and R.C. Detrano Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study Radiology 234 2005 35 43
14. A.S. Agatston, W.R. Janowitz, F.J. Hildner, N.R. Zusmer, M. Viamonte Jr., and R. Detrano Quantification of coronary artery calcium using ultrafast computed tomography J Am Coll Cardiol 15 1990 827 832
15. E.Y. Choi, H. Bahrami, C.O. Wu, P. Greenland, M. Cushman, L.B. Daniels, A.L. Almeida, K. Yoneyama, A. Opdahl, A. Jain, M.H. Criqui, D. Siscovick, C. Darwin, A. Maisel, D.A. Bluemke, and J.A. Lima N-terminal pro-B-type natriuretic peptide, left ventricular mass, and incident heart failure: Multi-Ethnic Study of Atherosclerosis Circ Heart Fail 5 2012 727 734
16. J.P. Fine, and R.J. Gray A proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 1999 496 509
17. S.L. Seliger, J. de Lemos, I.J. Neeland, R. Christenson, J. Gottdiener, M.H. Drazner, J. Berry, J. Sorkin, and C. deFilippi Older Adults, "malignant" left ventricular hypertrophy, and associated cardiac-specific biomarker phenotypes to identify the differential risk of new-onset reduced versus preserved ejection fraction heart failure: CHS (Cardiovascular Health Study) JACC Heart Fail 3 2015 445 455
18. T.E. Owan, D.O. Hodge, R.M. Herges, S.J. Jacobsen, V.L. Roger, and M.M. Redfield Trends in prevalence and outcome of heart failure with preserved ejection fraction N Engl J Med 355 2006 251 259
19. M.J. Lenzen, W.J. Scholte op Reimer, E. Boersma, P.J. Vantrimpont, F. Follath, K. Swedberg, J. Cleland, and M. Komajda Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey Eur Heart J 25 2004 1214 1220
20. Y. Gerber, S.A. Weston, C. Berardi, S.M. McNallan, R. Jiang, M.M. Redfield, and V.L. Roger Contemporary trends in heart failure with reduced and preserved ejection fraction after myocardial infarction: a community study Am J Epidemiol 178 2013 1272 1280
21. Y. Gerber, S.A. Weston, M. Enriquez-Sarano, C. Berardi, A.M. Chamberlain, S.M. Manemann, R. Jiang, S.M. Dunlay, and V.L. Roger Mortality associated with heart failure after myocardial infarction: a contemporary community perspective Circ Heart Fail 9 2016 e002460
22. W.J. Paulus, and C. Tschöpe A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation J Am Coll Cardiol 62 2013 263 271
23. B.W. Van Tassell, R. Arena, G. Biondi-Zoccai, J. McNair Canada, C. Oddi, N.A. Abouzaki, A. Jahangiri, R.A. Falcao, M.C. Kontos, K.B. Shah, N.F. Voelkel, C.A. Dinarello, and A. Abbate Effects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure and preserved ejection fraction (from the D-HART pilot study) Am J Cardiol 113 2014 321 327
24. K. McDonald, and T. Murphy Predict, protect, prevent: working toward a personalized approach to heart failure prevention JACC Heart Fail 3 2015 456 458
25. M. Ledwidge, J. Gallagher, C. Conlon, E. Tallon, E. O'Connell, I. Dawkins, C. Watson, R. O'Hanlon, M. Bermingham, A. Patle, M.R. Badabhagni, G. Murtagh, V. Voon, L. Tilson, M. Barry, L. McDonald, B. Maurer, and K. McDonald Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial JAMA 310 2013 66 74